483 Oxford Pharmaceuticals May 2019

483 Oxford Pharmaceuticals May 2019

Francis Guidry FDA$119.00 - Available Now

FDA investigators audited the Oxford Pharmaceuticals - Birmingham, AL, United States facility and issued inspectional observations (via FDA 483) on 22 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 22 May 2019
  • Location: Birmingham, United States
  • FEI: 3012257735
Add To Cart